205 related articles for article (PubMed ID: 8836613)
1. Functional evidence for the ability of angiotensin AT1 receptor antagonists to cross the blood-brain barrier in rats.
Polidori C; Ciccocioppo R; Pompei P; Cirillo R; Massi M
Eur J Pharmacol; 1996 Jul; 307(3):259-67. PubMed ID: 8836613
[TBL] [Abstract][Full Text] [Related]
2. The selective angiotensin AT1 receptor antagonist LR-B/081 potently inhibits drinking induced by central injection of angiotensin II in rats.
Polidori C; Ciccocioppo R; Pompei P; Cirillo R; Massi M
Eur J Pharmacol; 1995 Apr; 277(2-3):223-8. PubMed ID: 7493612
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the ability of irbesartan to cross the blood-brain barrier following acute intragastric treatment.
Polidori C; Ciccocioppo R; Nisato D; Cazaubon C; Massi M
Eur J Pharmacol; 1998 Jul; 352(1):15-21. PubMed ID: 9718262
[TBL] [Abstract][Full Text] [Related]
4. Effects of systemic treatment with irbesartan and losartan on central responses to angiotensin II in conscious, normotensive rats.
Culman J; von Heyer C; Piepenburg B; Rascher W; Unger T
Eur J Pharmacol; 1999 Feb; 367(2-3):255-65. PubMed ID: 10079000
[TBL] [Abstract][Full Text] [Related]
5. Insurmountable angiotensin AT1 receptor antagonists: the role of tight antagonist binding.
Fierens FL; Vanderheyden PM; De Backer JP; Vauquelin G
Eur J Pharmacol; 1999 May; 372(2):199-206. PubMed ID: 10395100
[TBL] [Abstract][Full Text] [Related]
6. Nonpeptide angiotensin II receptor antagonist: pharmacokinetics and pharmacodynamics in rats of EXP3174, an active metabolite of losartan.
Wong PC; Christ DD; Wong YN; Lam GN
Pharmacology; 1996 Jan; 52(1):25-9. PubMed ID: 8966199
[TBL] [Abstract][Full Text] [Related]
7. Nonpeptide angiotensin II receptor antagonists. XI. Pharmacology of EXP3174: an active metabolite of DuP 753, an orally active antihypertensive agent.
Wong PC; Price WA; Chiu AT; Duncia JV; Carini DJ; Wexler RR; Johnson AL; Timmermans PB
J Pharmacol Exp Ther; 1990 Oct; 255(1):211-7. PubMed ID: 2213556
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological profile of GR117289 in vitro: a novel, potent and specific non-peptide angiotensin AT1 receptor antagonist.
Robertson MJ; Barnes JC; Drew GM; Clark KL; Marshall FH; Michel A; Middlemiss D; Ross BC; Scopes D; Dowle MD
Br J Pharmacol; 1992 Dec; 107(4):1173-80. PubMed ID: 1467838
[TBL] [Abstract][Full Text] [Related]
9. Effect of peptide and nonpeptide antagonists of angiotensin II receptors on noradrenaline release in hypothalamus of rats with angiotensin II-induced increase of water intake.
Stancheva S; Alova L; Stefanova M
Pharmacol Rep; 2009; 61(6):1206-10. PubMed ID: 20081258
[TBL] [Abstract][Full Text] [Related]
10. Reversible and syntopic interaction between angiotensin receptor antagonists on Chinese hamster ovary cells expressing human angiotensin II type 1 receptors.
Vanderheyden PM; Fierens FL; De Backer J; Vauquelin G
Biochem Pharmacol; 2000 Apr; 59(8):927-35. PubMed ID: 10692557
[TBL] [Abstract][Full Text] [Related]
11. Pharmacology of LR-B/081, a new highly potent, selective and orally active, nonpeptide angiotensin II AT1 receptor antagonist.
Cirillo R; Renzetti AR; Cucchi P; Guelfi M; Salimbeni A; Caliari S; Castellucci A; Evangelista S; Subissi A; Giachetti A
Br J Pharmacol; 1995 Mar; 114(6):1117-24. PubMed ID: 7620700
[TBL] [Abstract][Full Text] [Related]
12. Losartan potassium, a nonpeptide antagonist of angiotensin II, chronically administered p.o. does not readily cross the blood-brain barrier.
Bui JD; Kimura B; Phillips MI
Eur J Pharmacol; 1992 Aug; 219(1):147-51. PubMed ID: 1397042
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological and pharmacokinetic evaluation of EXP3312, an orally-active non-peptide angiotensin II-receptor antagonist.
Wong YN; Wong PC
J Pharm Pharmacol; 1996 May; 48(5):492-7. PubMed ID: 8799873
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of losartan, an angiotensin II receptor antagonist, and its active metabolite EXP3174 in humans.
Lo MW; Goldberg MR; McCrea JB; Lu H; Furtek CI; Bjornsson TD
Clin Pharmacol Ther; 1995 Dec; 58(6):641-9. PubMed ID: 8529329
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological profile of a highly potent and long-acting angiotensin II receptor antagonist, 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4- yl]methyl]-1H-benzimidazole-7-carboxylic acid (CV-11974), and its prodrug, (+/-)-1-(cyclohexyloxycarbonyloxy)-ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5- yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate (TCV-116).
Shibouta Y; Inada Y; Ojima M; Wada T; Noda M; Sanada T; Kubo K; Kohara Y; Naka T; Nishikawa K
J Pharmacol Exp Ther; 1993 Jul; 266(1):114-20. PubMed ID: 8331552
[TBL] [Abstract][Full Text] [Related]
16. Antihypertensive effects of a highly potent and long-acting angiotensin II subtype-1 receptor antagonist, (+-)-1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H- benzimidazole-7-carboxylate (TCV-116), in various hypertensive rats.
Inada Y; Wada T; Shibouta Y; Ojima M; Sanada T; Ohtsuki K; Itoh K; Kubo K; Kohara Y; Naka T
J Pharmacol Exp Ther; 1994 Mar; 268(3):1540-7. PubMed ID: 8138966
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin II-induced responses in vascular smooth muscle cells: inhibition by non-peptide receptor antagonists.
Catalioto RM; Porchia R; Renzetti AR; Criscuoli M; Subissi A; Giachetti A
Eur J Pharmacol; 1995 Jul; 280(3):285-92. PubMed ID: 8566096
[TBL] [Abstract][Full Text] [Related]
18. BMS-180560, an insurmountable inhibitor of angiotensin II-stimulated responses: comparison with losartan and EXP3174.
Dickinson KE; Cohen RB; Skwish S; Delaney CL; Serafino RP; Poss MA; Gu Z; Ryono DE; Moreland S; Powell JR
Br J Pharmacol; 1994 Sep; 113(1):179-89. PubMed ID: 7812609
[TBL] [Abstract][Full Text] [Related]
19. Binding of angiotensin antagonists to rat liver and brain membranes measured ex vivo.
Marshall FH; Clark SA; Michel AD; Barnes JC
Br J Pharmacol; 1993 Jul; 109(3):760-4. PubMed ID: 8358571
[TBL] [Abstract][Full Text] [Related]
20. Dihydropyrimidine angiotensin II receptor antagonists.
Atwal KS; Ahmed SZ; Bird JE; Delaney CL; Dickinson KE; Ferrara FN; Hedberg A; Miller AV; Moreland S; O'Reilly BC
J Med Chem; 1992 Dec; 35(25):4751-63. PubMed ID: 1469703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
